Benitec Biopharma Growth Metrics (2019-2025) | BNTC

Growth Metrics Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
-37.18M-20.10M30.66M37.21M-2.07M-0.08M
EBITDA Margin Growth (3y) (Quarter)
-3.73M-0.05M-7.32M
EBITDA Margin (QoQ) (Quarter)
-5.34M18.66M1.21M3.20M-5.70M
EBIT Margin Growth (1y) (Quarter)
-37.18M-20.10M30.66M37.21M-2.07M-0.08M
EBIT Margin Growth (3y) (Quarter)
-3.73M-0.05M-7.32M
EBIT Margin (QoQ) (Quarter)
-5.34M18.66M1.21M3.20M-5.70M
EBT Margin Growth (1y) (Quarter)
-37.26M-24.86M33.83M37.26M-2.53M-0.33M
EBT Margin Growth (3y) (Quarter)
-4.25M-0.33M-28.10M
EBT Margin (QoQ) (Quarter)
-2.19M17.77M1.24M3.44M-22.40M
Enterprise Value Growth (1y) (Quarter)
-5.16%-101.86%-110.74%12.00%28.01%79.40%-5.18%14.42%23.36%38.91%-56.71%-93.23%99.80%-1,945.34%-162.26%-284.27%-796,692.31%-92.14%-39.38%-141.11%
Enterprise Value Growth (3y) (Quarter)
36.23%0.24%8.53%16.60%36.67%-51.44%-13.32%89.73%-37.05%-62.90%-85.22%-128.96%-188.48%-78.93%-161.61%
Enterprise Value Growth (5y) (Quarter)
-26.51%-32.48%-41.55%-55.48%-58.44%-66.24%-68.25%
Enterprise Value (QoQ) (Quarter)
14.43%-65.03%20.64%21.47%30.00%52.77%-305.13%36.10%37.31%62.35%-939.24%21.21%99.94%-391,661.54%-33.25%-15.44%-32.21%5.53%3.34%-99.70%
FCF Margin Growth (1y) (Quarter)
-19.77M-25.98M33.28M19.33M-2.86M-0.04M
FCF Margin Growth (3y) (Quarter)
-3.78M-0.47M-6.74M
FCF Margin (QoQ) (Quarter)
14.56M-5.04M0.61M3.44M-5.09M
Interest Coverage Ratio Growth (1y) (Quarter)
-9,142.75%87.42%-215.26%94.79%98.69%72.93%75.74%88.30%-45.12%-200.01%92.04%99.59%99.38%99.99%99.83%89.24%-1,166,407.89%52.65%-86,823.06%
Interest Coverage Ratio Growth (3y) (Quarter)
-20.78%53.25%60.67%97.09%95.10%96.17%96.80%96.29%-371.38%95.38%51.10%
Interest Coverage Ratio Growth (5y) (Quarter)
-163.56%91.96%38.30%
Interest Coverage Ratio (QoQ) (Quarter)
-4,599.06%95.77%-5.33%-50.40%22.30%98.93%-2,070.74%-34.79%62.52%86.77%-4,387.51%96.43%98.09%79.80%49.67%12.90%-21.46%-2,190,400.15%100.00%-159,792.44%
Net Margin Growth (1y) (Quarter)
-37.26M-24.86M33.83M37.26M-2.53M-0.33M
Net Margin Growth (3y) (Quarter)
-4.25M-0.33M-28.10M
Net Margin (QoQ) (Quarter)
-2.19M17.77M1.24M3.44M-22.40M
Operating Margin Growth (1y) (Quarter)
-37.18M-20.10M30.66M37.21M-2.07M-0.08M
Operating Margin Growth (3y) (Quarter)
-3.73M-0.05M-7.32M
Operating Margin (QoQ) (Quarter)
-5.34M18.66M1.21M3.20M-5.70M
Return on Assets Growth (1y) (Quarter)
1.001.000.00M-4.00-2.00-1.00-3.00-1.001.001.00-18.00-76.00-123.00-241.00-283.0037.00
Return on Assets Growth (3y) (Quarter)
0.00M0.00M-20.00-80.00-125.00-242.00-406.00-204.00
Return on Assets Growth (5y) (Quarter)
-407.00-204.00
Return on Assets (QoQ) (Quarter)
0.00M1.000.00M0.00M0.00M-3.001.001.00-1.00-1.003.000.00M-20.00-59.00-44.00-118.00202.00
Return on Capital Employed Growth (1y) (Quarter)
0.00M-0.00M-0.01M-0.02M-0.01M-0.00M-0.01M-0.05M0.00M0.00M0.01M0.07M0.01M0.01M-774.00271.00
Return on Capital Employed Growth (3y) (Quarter)
-0.01M-0.00M-0.00M638.000.00M0.01M0.01M0.01M
Return on Capital Employed Growth (5y) (Quarter)
0.01M0.01M
Return on Capital Employed (QoQ) (Quarter)
-928.000.00M-255.00-0.00M-0.00M-0.02M0.01M0.00M-0.01M-0.05M0.06M0.01M-0.00M0.01M0.00M295.000.00M
Return on Sales Growth (1y) (Quarter)
-0.00M-0.00M-0.00M0.00M0.00M0.00M0.00M-253.00-33.00-0.00M38.00-313.00-0.06M
Return on Sales Growth (3y) (Quarter)
-467.00-425.00-33.00-0.00M-415.000.00M-0.05M
Return on Sales (QoQ) (Quarter)
-219.000.00M-0.00M0.00M124.00-423.00-5.0050.00344.00-0.00M0.00M-301.00-0.06M